{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T10:32:52Z","timestamp":1766313172313,"version":"3.48.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ymgmr.2025.101260","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:14:38Z","timestamp":1760141678000},"page":"101260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lactic acidosis, rhabdomyolysis, and hyperammonemia: Atypical presentation in a new patient with PDE-ALDH7A1 defect"],"prefix":"10.1016","volume":"45","author":[{"given":"Marina","family":"Bottino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maija R.","family":"Steenari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebekah","family":"Barrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose E.","family":"Abdenur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2025.101260_bb0005","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1136\/adc.2005.075069","article-title":"Epidemiology of pyridoxine dependent seizures in the Netherlands","volume":"90","author":"Been","year":"2005","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/jimd.12045","article-title":"The genotypic spectrum of ALDH7A1 mutations resulting in pyridoxine dependent epilepsy: a common epileptic encephalopathy","volume":"42","author":"Coughlin","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pediatrneurol.2015.12.013","article-title":"Pyridoxine-dependent epilepsy: an expanding clinical Spectrum","volume":"59","author":"Van Karnebeek","year":"2016","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0020","doi-asserted-by":"crossref","DOI":"10.1111\/epi.16408","article-title":"Diagnosis of pyridoxine-dependent epilepsy in an adult presenting with recurrent status epilepticus","volume":"61","author":"Osman","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.ymgmr.2025.101260_bb0025","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/jimd.12332","article-title":"Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to \u03b1-aminoadipic semialdehyde dehydrogenase deficiency","volume":"44","author":"Coughlin","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2024.107363","article-title":"Genotype and phenotype features and prognostic factors of neonatal-onset pyridoxine-dependent epilepsy: a systematic review","volume":"202","author":"Fang","year":"2024","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0035","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jimd.12059","article-title":"Identification of a novel biomarker for pyridoxine-dependent epilepsy: implications for newborn screening","volume":"42","author":"Wempe","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0040","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207829","article-title":"Pearls & oy-sters: delayed response to pyridoxine in pyridoxine-dependent epilepsy","volume":"101","author":"Fortin","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.ymgmr.2025.101260_bb0045","first-page":"188","article-title":"Dietary management for pyridoxine-dependent epilepsy due to \u03b1-aminoadipic semialdehyde dehydrogenase deficiency, a follow-on from the international consortium guidelines","volume":"65","author":"Dixon","year":"2024","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.940103","article-title":"Case report: fatal outcome of pyridoxine-dependent epilepsy presenting as respiratory distress followed by a circulatory collapse","volume":"10","author":"Aquilano","year":"2022","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0055","doi-asserted-by":"crossref","first-page":"e1368","DOI":"10.1542\/peds.2011-0123","article-title":"Profound neonatal hypoglycemia and lactic acidosis caused by pyridoxine-dependent epilepsy","volume":"129","author":"Mercimek-Mahmutoglu","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgmr.2025.101260_bb0060","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s11011-016-9869-z","article-title":"Pyridoxine-dependent epilepsy: report on three families with neuropathology","volume":"31","author":"Marguet","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0065","doi-asserted-by":"crossref","DOI":"10.1093\/omcr\/omaa008","article-title":"A case of pyridoxine-dependent epilepsy with novel ALDH7A1 mutations","volume":"2020","author":"Dowa","year":"2020","journal-title":"Oxf. Med. Case Rep."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pediatrneurol.2023.08.032","article-title":"Pyridoxine-dependent epilepsy with poor neurodevelopmental outcome: case report","volume":"149","author":"Chauhan","year":"2023","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0075","first-page":"1","article-title":"An atypical presentation of pyridoxine-dependent epilepsy diagnosed with whole exome sequencing and treated with lysine restriction and supplementation with arginine and pyridoxine","volume":"2022","author":"Kim","year":"2022","journal-title":"Case Rep. Genet."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0080","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1017\/S0317167100014050","article-title":"Variability of phenotype in two sisters with pyridoxine dependent epilepsy","volume":"39","author":"Alfadhel","year":"2012","journal-title":"Can. J. Neurol. Sci. J. Can. Sci. Neurol."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0085","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/s12883-024-03936-1","article-title":"Pyridoxine-dependent epilepsy caused by an ALDH7A1 mutation in an infant girl: the first case report in Syria","volume":"24","author":"Jaber","year":"2024","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0090","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00431-008-0823-x","article-title":"Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 north American cases submitted to a patient registry","volume":"168","author":"Basura","year":"2009","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0095","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/brain\/awq143","article-title":"Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency)","volume":"133","author":"Mills","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ymgmr.2025.101260_bb0100","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.ejpn.2018.06.010","article-title":"Brain malformations associated to Aldh7a1 gene mutations: report of a novel homozygous mutation and literature review","volume":"22","author":"Toldo","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0105","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000201222","article-title":"On behalf of the international PDE consortium, association between lysine reduction therapies and cognitive outcomes in patients with pyridoxine-dependent epilepsy","volume":"99","author":"Coughlin","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.ymgmr.2025.101260_bb0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm1366","article-title":"Mutations in antiquitin in individuals with pyridoxine-dependent seizures","volume":"12","author":"Mills","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0115","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ymgme.2007.04.016","article-title":"\u0391-Aminoadipic semialdehyde is the biomarker for pyridoxine dependent epilepsy caused by \u03b1-aminoadipic semialdehyde dehydrogenase deficiency","volume":"91","author":"Struys","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0120","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10545-011-9443-0","article-title":"The measurement of urinary \u03941 -piperideine-6-carboxylate, the alter ego of \u03b1-aminoadipic semialdehyde, in Antiquitin deficiency","volume":"35","author":"Struys","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0125","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-2005-865727","article-title":"Pipecolic acid as a diagnostic marker of pyridoxine-dependent epilepsy","volume":"36","author":"Plecko","year":"2005","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgmr.2025.101260_bb0130","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148272","article-title":"Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy","volume":"131","author":"Engelke","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/jn\/101.2.185","article-title":"Effect of vitamin B6 depletion in adult man on the plasma concentration and the urinary excretion of free amino acids","volume":"101","author":"Park","year":"1971","journal-title":"J. Nutr."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0140","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1093\/hmg\/ddaa202","article-title":"A novel mouse model for pyridoxine-dependent epilepsy due to antiquitin deficiency","volume":"29","author":"Al-Shekaili","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257073","article-title":"Is impaired energy production a novel insight into the pathogenesis of pyridoxine-dependent epilepsy due to biallelic variants in ALDH7A1?","volume":"16","author":"Minenkova","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgmr.2025.101260_bb0150","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1097-2765(00)80295-6","article-title":"Targeting of a human iron\u2013sulfur cluster assembly enzyme, nifs, to different subcellular compartments is regulated through alternative AUG utilization","volume":"2","author":"Land","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymgmr.2025.101260_bb0155","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011312","article-title":"The role of mitochondria in cellular Iron-sulfur protein biogenesis: mechanisms, connected processes, and diseases","volume":"5","author":"Stehling","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0160","doi-asserted-by":"crossref","first-page":"26737","DOI":"10.1074\/jbc.R110.118679","article-title":"Frataxin and mitochondrial FeS cluster biogenesis","volume":"285","author":"Stemmler","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1242\/dmm.009019","article-title":"Biogenesis of iron-sulfur clusters in mammalian cells: new insights and relevance to human disease","volume":"5","author":"Rouault","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0170","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/humu.24330","article-title":"Expanding the phenotypic and molecular spectrum of NFS1 -related disorders that cause functional deficiencies in mitochondrial and cytosolic iron\u2013sulfur cluster containing enzymes","volume":"43","author":"Yang","year":"2022","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1090-3798(98)80041-X","article-title":"Mcardle\u2019s disease in childhood: report of a new case","volume":"2","author":"Roubertie","year":"1998","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0180","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1212\/WNL.28.11.1124","article-title":"Fatal infantile form of muscle phosphorylase deficiency","volume":"28","author":"DiMauro","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/j.ymgmr.2025.101260_bb0185","first-page":"402","article-title":"Myophosphorylase deficiency - a new cause of infantile hypotonia simulating infantile muscular-atrophy","volume":"30","author":"De La Maza","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.ymgmr.2025.101260_bb0190","article-title":"Ornithine aminotransferase deficiency presenting with hyper-ammonaemia in a premature newborn","volume":"22","author":"Webster","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0195","article-title":"Ornithine aminotransferase deficiency (gyrate atrophy) presenting with hyperammonaemic encephalopathy","volume":"25","author":"Champion","year":"2002","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0200","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10545-005-0074-1","article-title":"Ornithine aminotransferase deficiency: diagnostic difficulties in neonatal presentation","volume":"28","author":"Cleary","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0205","series-title":"The Proline\/Citrulline Ratio as a Biomarker for OAT Deficiency in Early Infancy","first-page":"95","author":"De Sain-van Der","year":"2012"},{"key":"10.1016\/j.ymgmr.2025.101260_bb0210","article-title":"A neonate with ornithine aminotransferase deficiency; insights on the hyperammonemia-associated biochemical phenotype of gyrate atrophy","volume":"31","author":"Kaczmarczyk","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0215","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ymgme.2022.02.005","article-title":"Timing of therapy and neurodevelopmental outcomes in 18 families with pyridoxine-dependent epilepsy","volume":"135","author":"Tseng","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0220","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymgme.2015.05.011","article-title":"Triple therapy with pyridoxine, arginine supplementation and dietary lysine restriction in pyridoxine-dependent epilepsy: neurodevelopmental outcome","volume":"116","author":"Coughlin","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0225","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11011-016-9933-8","article-title":"Phenotype, biochemical features, genotype and treatment outcome of pyridoxine-dependent epilepsy","volume":"32","author":"Al Teneiji","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0230","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a006197","article-title":"A case for newborn screening for pyridoxine-dependent epilepsy","author":"Coughlin","year":"2022","journal-title":"Mol. Case Stud."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.109002","article-title":"Feasibility of newborn screening for pyridoxine-dependent epilepsy","volume":"144","author":"Pauly","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101260_bb0240","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1515\/cclm-2024-1230","article-title":"Inclusion of pyridoxine dependent epilepsy in expanded newborn screening programs by tandem mass spectrometry: set up of first and second tier tests","volume":"CCLM 63","author":"Damiano","year":"2025","journal-title":"Clin. Chem. Lab. Med."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426925000758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426925000758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T10:31:40Z","timestamp":1766313100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426925000758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":48,"alternative-id":["S2214426925000758"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2025.101260","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lactic acidosis, rhabdomyolysis, and hyperammonemia: Atypical presentation in a new patient with PDE-ALDH7A1 defect","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2025.101260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101260"}}